IMRX (Immuneering Corporation) Earnings growth in current year

Official company branding of immuneering.com (IMRX)

Immuneering Corporation bases its developments on an analytical platform for creating targeted drugs. The current structural stability is maintained through raised capital, as there are no mature products. The absence of approved drugs results in zero revenue. The year-over-year percentage change in EPS demonstrates the startup's volatility, with 1.00 representing the latest reading of the metric.

IMRX (Immuneering) Earnings growth in current year history from 07/04/2022 to 11/17/2026

Comprehensive metric breakdowns and analytics for Immuneering Corporation (IMRX)

- share price and expert price forecast:
Fundamental valuation:IMRX Immuneering Inc.
Signature product of Immuneering Corp.

For Immuneering Corporation (IMRX), which utilizes biological databases to develop targeted drugs, the annual earnings per share (EPS) growth rate serves as an indicator of how effectively the company monetizes its accumulated scientific capital. This metric calculates the percentage deviation of current earnings per share from the previous year's value, allowing investors to assess the business's maturity stage and the risk of capital stagnation during false breakouts.

Direct competitors

GMAB: Net earnings per one share growth for the current year|EXEL (Exelixis Inc.) - Earnings growth in current year|Earnings growth in current year nuvalent.com|Earnings per share growth in current year Kymera (KYMR)|IDYA (IDEAYA Biosciences, Inc.) - Earnings per share increase in current year|Earnings growth in current year ELVN (Enliven Therapeutics Inc)|Net earnings per share change in current year ORIC Pharma|Relay Therapeutics Inc - Earnings growth in current year|Earnings per share growth rate in current year Nurix Therapeutics, Inc.|TYRA (Tyra Biosciences, Inc.) - Net earnings per share growth this year|VSTM: Net earnings per one share growth for the current year|GLUE (monterosatx.com) - Earnings growth in current year|Earnings per share growth rate in current year Cullinan Therapeutics Inc CGEM|Earnings growth in current year CCCC|Black Diamond Therapeutics - Earnings per share growth this year|Repare Therapeutics Inc. - Net earnings per share growth this year|Earnings per share increase in current year PMVP|KPTI: Net earnings per share growth this year|propanc.com - Net earnings per one share growth for the current year|BGMS: Earnings growth in current year|Aadi Bioscience Inc - Earnings per share increase in current year|ALRN (Aileron Therapeutics Inc) - Earnings growth in current year|Earnings per share growth rate in current year blueprintmedicines.com BPMC|Earnings per share growth in current year GlycoMimetics Inc. (GLYC)|SWTX (SpringWorks) - Earnings per share increase in current year